Salud financiera de hoja de balance de Vaishali Pharma
Salud financiera controles de criterios 4/6
Vaishali Pharma tiene un patrimonio de accionistas total de ₹442.8M y una deuda total de ₹150.5M, lo que sitúa su ratio deuda-patrimonio en 34%. Sus activos y pasivos totales son ₹801.7M y ₹358.9M respectivamente. El BAIT de Vaishali Pharma es de ₹84.3M, por lo que su ratio de cobertura de intereses es de 9.7. Tiene efectivo e inversiones a corto plazo que ascienden a ₹4.3M.
Información clave
31.5%
Ratio deuda-patrimonio
₹134.92m
Deuda
Ratio de cobertura de intereses | 0.4x |
Efectivo | ₹15.78m |
Patrimonio | ₹428.39m |
Total pasivo | ₹371.16m |
Activos totales | ₹799.56m |
Actualizaciones recientes sobre salud financiera
Is Vaishali Pharma (NSE:VAISHALI) A Risky Investment?
Dec 11Vaishali Pharma (NSE:VAISHALI) Seems To Use Debt Quite Sensibly
Dec 10These 4 Measures Indicate That Vaishali Pharma (NSE:VAISHALI) Is Using Debt Reasonably Well
Feb 10Does Vaishali Pharma (NSE:VAISHALI) Have A Healthy Balance Sheet?
Jan 19Recent updates
A Piece Of The Puzzle Missing From Vaishali Pharma Limited's (NSE:VAISHALI) 27% Share Price Climb
Sep 13The Market Lifts Vaishali Pharma Limited (NSE:VAISHALI) Shares 26% But It Can Do More
Jul 05Here's Why Vaishali Pharma (NSE:VAISHALI) Has Caught The Eye Of Investors
Jan 17Vaishali Pharma Limited's (NSE:VAISHALI) Shares Leap 30% Yet They're Still Not Telling The Full Story
Dec 18Is Vaishali Pharma (NSE:VAISHALI) A Risky Investment?
Dec 11We Ran A Stock Scan For Earnings Growth And Vaishali Pharma (NSE:VAISHALI) Passed With Ease
Oct 04With EPS Growth And More, Vaishali Pharma (NSE:VAISHALI) Makes An Interesting Case
Feb 04Vaishali Pharma (NSE:VAISHALI) Seems To Use Debt Quite Sensibly
Dec 10We Ran A Stock Scan For Earnings Growth And Vaishali Pharma (NSE:VAISHALI) Passed With Ease
Aug 20Should You Be Adding Vaishali Pharma (NSE:VAISHALI) To Your Watchlist Today?
May 19These 4 Measures Indicate That Vaishali Pharma (NSE:VAISHALI) Is Using Debt Reasonably Well
Feb 10A Look At The Intrinsic Value Of Vaishali Pharma Limited (NSE:VAISHALI)
Aug 17A Look At The Fair Value Of Vaishali Pharma Limited (NSE:VAISHALI)
May 17Are Vaishali Pharma Limited's (NSE:VAISHALI) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Mar 17Calculating The Fair Value Of Vaishali Pharma Limited (NSE:VAISHALI)
Feb 15Does Vaishali Pharma (NSE:VAISHALI) Have A Healthy Balance Sheet?
Jan 19Are Vaishali Pharma Limited's (NSE:VAISHALI) Mixed Financials Driving The Negative Sentiment?
Nov 23Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (₹740.7M) de VAISHALI superan a sus pasivos a corto plazo (₹306.2M).
Pasivo a largo plazo: Los activos a corto plazo de VAISHALI (₹740.7M) superan a sus pasivos a largo plazo (₹52.7M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: El ratio deuda neta-patrimonio (33%) de VAISHALI se considera satisfactorio.
Reducción de la deuda: El ratio deuda-patrimonio de VAISHALI ha pasado de 79.8% a 34% en los últimos 5 años.
Cobertura de la deuda: La deuda de VAISHALI no está bien cubierta por el flujo de caja operativo (6.4%).
Cobertura de intereses: Los pagos de intereses de la deuda de VAISHALI no están bien cubiertos por el BAIT (1.5x cobertura).